Providing physicians with innovative and meaningful assays for the earlier detection of clinically significantly prostate cancer.

MDxHealth uses a molecular (gene-based) technology to improve cancer diagnosis and treatment.

Individual genes (DNA biomarkers) in the human body can become modified in the presence of cancer. MDxHealth has the ability to identify these modifications at the genetic level providing the physicians with a tool to aid in the diagnosis of cancer.

Our Tests

& Billing

We are committed to making our tests accessible and affordable to your patients.

Report Access

SecureMDx is a safe and secure HIPAA compliant tool that gives you access to patient reports online.

About MDxHealth

MDxHealth is a multinational healthcare company delivering life changing genomic technologies to improve the early detection of prostate cancer.